BridgeMD
New treatment option for Clinical High Risk for Psychosis (CHR)
Official title Interventions for Clinical High Risk Youth in Tunisia
ClinicalTrials.gov ID: NCT06582901
What this study is testing
- What it's testing
- Study participants will take part in one of the two types of treatments aimed at improving daily functioning as follows: either a Cognitive Training (CT) Program or an Enhanced - Treatment as Usual (E-TAU) Group. All group treatments will be provided at Razi Hospital and one of the sessions will be conducted at home.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 28
You may be able to join if
- Meets Comprehensive Assessment for At Risk Mental States (CAARMS) criteria for Clinical High Risk
- If under the age of 18, the subject has a parent or guardian who can sign consent forms
- Premorbid Intelligence Quotient not less than 70
- Sufficient fluency in Arabic, French, or English to avoid invalidating research measures
- Residence likely within commuting distance of Razi University Hospital
You likely can't join if
- Evidence of known neurological disorder, e.g. epilepsy or significant head injury that could account for the CHR symptoms
- Evidence of significant and habitual alcohol or substance use in the 6 months prior to study entry
- Evidence that the clinical high-risk symptoms were substance-induced
The study team makes the final eligibility decision.
Where it's taking place
- Tunis, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 28 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tunis, Tunisia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.